To ensure clinical significance, we examined the AKR1C1 levels using surgically resected specimens derived from bladder cancer patients, including 33 primary and 5 metastatic lesions involving the lymph nodes (n = 3), lungs (n = 1), and liver (n = 1). This evidence concerns the gene AKR1C1 and urinary bladder carcinoma.